A pharmacokinetic comparison of the corn oil versus microemulsion gelcap formulation of cyclosporin used de nova after renal transplantation

Transplant International

Volumn 10, Issue 3, 1997, Pages 217-222

  Amante, Angel J ^a   Meier Kriesche, Herwig Ulf ^a   Schoenberg, Linda ^a   Kahan, Barry D ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Corn oil, cyclosporin; Cyclosporin, microemulsion formulation; Microemulsion formulation, cyclosporin

Indexed keywords

CORN OIL; CYCLOSPORIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CAPSULE; DRUG FORMULATION; FEMALE; GEL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; MICROEMULSION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, ORAL; ADULT; BIOLOGICAL AVAILABILITY; CAPSULES; CORN OIL; CYCLOSPORINE; EMULSIONS; FEMALE; GELS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; TIME FACTORS;

EID: 0030954975     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001470050045     Document Type: Article

References (12)

1. Grevel J (1986) Absorption of cyclosporine A after oral dosing. Transplant Proc 18 [Suppl 5]: 9-15
2. Kahan BD, Welsh M, Rutzky L, Lewis R, Knight R, Katz S, Napoli K, Grevel J, Van Buren CT (1992) The ability of pretransplant test-dose pharmacokinetic profiles to reduce early adverse events after renal transplantation. Transplantation 53: 345-351
3. Kahan BD, Dunn J, Fitts C, Van Buren D, Wombolt D, Pollak R, Carson R, Alexander J, Chang C, Choc M, Wong R (1994) The Neoral formulation: improved correlation between cyclosporine trough levels and exposure in stable renal transplant recipients. Transplant Proc 26: 2940-2943
4. Kovank JM, Mueller EA, Van Bree JB, Fluckiger SS, Lange H, Schmidt B, Boesken WH, Lison AE, Kutz K (1994) Cyclosporine pharmacokinetics and variability from a microemulsion formulation - a multicenter investigation in kidney transplant patients. Transplantation 58: 658-663
5. Kovarik JM, Mueller EA, Van Bree JB, Tetzloff W, Kutz K (1994) Reduced inter- and intraindividual variability in cyclosporine pharmacokinetics from a microemulsion formulation. J Pharm Sci 83: 444-446
6. Lindholm A. Kahan BD (1993) Influence of cyclosporine pharmacokinetic parameters, trough concentrations and AUC monitoring on outcome after kidney transplantation. Clin Pharmacol Ther 54: 205-218
7. Norusis MJ (1993) SPSS for Windows Base System User's Guide. Release 6.0. SPSS. Chicago, p 311
8. Norusis MJ (1996) SPSS Advanced Statistics, 7.0 Update, SPSS, Chicago, pp 35-48
9. Ohlman S, Lindholm A, Hagglund H, Sawe J, Kahan BD (1993) On the intra-individual variability and chronobiology of cyclosporine pharmacokinetics in renal transplantation. Eur J Clin Pharmacol 44: 265-269
10. Ritschel WA (1992) Handbook of basic pharmacokinetics, 4th edn. Drug Intel-ligence Publications, Hamilton, Ill., p 356
11. Trull AK, Tan KKC, Uttridge J, Bauer T, Alexander GJM. Jamieson NV (1993) Cyclosporine absorption from microemulsion formulation in liver transplant recipient (letter). Lancet 341: 433
12. Tufveson G, Odlind B, Sjoberg A, Lindberg A, Gabrielsson J. Lindstrom B, Lithell H, Selinus I, Totterman T, Wahlberg J (1986) A longitudinal study of the pharmacokinetics of cyclosporin A and in vitro lymphocyte responses in renal transplant patients. Transplant Proc 18 [Suppl 5]: 16-24